The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Associate Professor Bourne’s research will involve learning how the infant brain has an enhanced capacity to repair its own neocortex following an injury and to translate these findings into the development of brain regenerative therapies.
Understanding The Pathophysiology Of Schizophrenia, Major Depressive Disorder And Bipolar Disorder As A Basis For Improving Treatments
Funder
National Health and Medical Research Council
Funding Amount
$804,106.00
Summary
The Applicant seeks to understand the causes of the schizophrenia, bipolar disorder and major depressive disorder, which affect over 20% of the Australian population. This research is important as drug design, based on chemical remodelling, has not significantly advanced initial breakthroughs in treating psychiatric disorders and there is now a widespread belief that new drugs will only come from understand their causes.
The aim of this research project is to provide critical new information on the functional changes in brain circuits mediating cognitive-emotional integration during decision-making. This project will use a powerful and unique combination of behavioural, circuit-level, cellular, genetic and imagining tools to assess decision processes in healthy rodent and human subjects, and in animal models of, and humans suffering from, specific psychiatric disorders.
The mammalian cerebral cortex is an area of the brain responsible for all higher order cognitive processes. I investigate how connections from between the two cerebral hemispheres during embryonic and foetal development, thus enabling the brain to coordinate information from the two sides of the body. Malformations of these connections cause mental retardation and sensory and motor deficits. I want to understand how these brain defects occur and how best to treat them.
I am an epidemiologist investigating: 1) the frequency, pathogenesis, risk factors and impacts of common age-related eye disease, particularly focused on the four leading causes of blindness: age-related macular degeneration, cataract, glaucoma and diabetic retinopathy; 2) the potential for screening and clinical diagnostic value of retinal imaging and retinal vascular signs as predictors of major systemic conditions such as hypertension, diabetes and cardiovascular disease.
Imaging Atlases Of The Brain Of Humans And Experimental Animals
Funder
National Health and Medical Research Council
Funding Amount
$808,375.00
Summary
This project uses imaging techniques and molecular genetics to produce the next generation of brain maps. It will advance our understanding of the organisation and structure of the brain and spinal cord of humans and experimental animals – paving the way for the development of psychotherapeutic drugs and more accurate interventions on the human brain. The new maps will help those who study the brain of patients with diseases such as Alzheimer’s or Parkinson’s or animal models of these diseases.
Promoting Recovery After Neurotrauma: Basic Science, Clinical Trials And Community Engagement
Funder
National Health and Medical Research Council
Funding Amount
$356,269.00
Summary
To promote recovery after neurotrauma by controlling the spread of damage and by maximising function in surviving circuits. The work involves animal models & nanotechnology as well as clinical rehabilitation trials in humans with spinal cord injury.